TUESDAY, Sept. 3, 2019 -- Drugs called tyrosine kinase inhibitors can help certain patients with advanced lung cancer live longer and better. But high out-of-pocket costs might stand in the way, a preliminary study suggests. Researchers found that...
Original Article: Paperwork, High Costs Could Mean Worse Survival for Lung Cancer Patients